| Literature DB >> 35517368 |
Fang Zhao1, Wenzhu Li1, Jianyang Pan1, Zeqi Chen1, Haibin Qu1.
Abstract
Herbal medicines have played a vital role in maintaining the health of the world population in the past thousands of years, and have proved to be an effective therapy. It is important to improve our understanding of the effects of the multi-step processing in herbal medicines on the chemical changes to ensure product quality. A proton nuclear paramagnetic resonance (1H NMR)-based evaluation strategy was developed for an efficient process variation exploration and diversified metabolite identification. In this study, 48 process intermediates from 6 commercial batches of the multi-step manufacturing chain of Danshen processing were obtained. Hierarchical classification analysis (HCA) tree based on 1H NMR spectra clustered the samples according to the processing steps, which indicates that 1H NMR has the potential capability for critical control point identification based on its adequate information of the organic compounds. Then, principal component analysis (PCA) and orthogonal partial least squares-discriminant analysis (OPLS-DA) were applied to distinguish the major metabolite differences between the intermediates before and after the critical control point. In this case, the alkali-isolation and acid-dissolution method was recognized as the most critical process in the multi-step chain of Danshen extract manufacturing. Potential metabolites with the larger amplitude of variation and contributing the most to the discrimination were found to be potential quality markers by S-plot, including several previously undetected amino acids. The results in this study are consistent with previous research studies and reference experiments conducted with other analytical tools. Taken together, they prove that 1H NMR with chemometrics is a very effective process quality control tool to provide comprehensive information on the chemical changes during the processing of herbal medicines, and help with the identification of critical control points and potential critical quality markers. This journal is © The Royal Society of Chemistry.Entities:
Year: 2020 PMID: 35517368 PMCID: PMC9054755 DOI: 10.1039/d0ra03172k
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Fig. 11H NMR spectra of Danshen extracts and expansions of a representative spectrum: (A) are preprocessed 1H NMR spectra of the process intermediates collected from production batch 1, colored by the intermediate number A–G, (B) is the enlarged organic and amino acid region, (C) is the enlarged fatty hydrocarbon region and (D) is the enlarged aromatic region. (B)–(D) are all parts of the 1H NMR spectrum of intermediate G collected from production batch 1.
Chemical shifts for metabolites identified in the 1H NMR spectra of a Danshen water extract solution
| Peak | Metabolites |
|
|---|---|---|
| 1 | Isoleucine | 3.66(m), 1.96(m), 1.47(m), 1.26(m), 1.01(d), 0.96(t) |
| 2 | Leucine | 3.72(m), 1.67(m), 0.95(m) |
| 3 | Valine | 3.60(d), 2.26(m), 1.05(d), 1.00(d) |
| 4 | Lactate | 4.09(m), 1.29(d) |
| 5 | Threonine | 4.25(m), 3.58(d), 1.39(d) |
| 6 | Alanine | 3.78(m), 1.48(d) |
| 7 | Acetate | 1.95(s) |
| 8 | Proline | 4.13(m), 3.42(m), 3.34(m), 2.00(m) |
| 9 | Pyroglutamate | 2.76(dd), 2.97(dd), 4.00(m) |
| 10 | Glutamine | 3.79(m), 2.45(m), 2.15(m) |
| 11 | Succinic | 2.42(s) |
| 12 | Malate | 4.31(m), 2.68(dd), 2.37 |
| 13 | Choline | 3.21(s) |
| 14 | Glucose | 5.27(d), 4.68(d), 3.94(dd), 3.87(m), 3.77(m), 3.56(m), 3.50(m), 3.44(m), 3.28(dd) |
| 15 | Fructose | 3.99(dd), 3.91(dd), 3.88(dt), 3.78(dd), 3.58(m), 3.46(m), 3.43(d) |
| 16 | Manninotriose | 5.05(m), 5.02(m), 4.93(m), 4.79(d), 4.74(d), 4.15(dd), 3.99(d), 3.94(m), 3.88(m), 3.76(m), 3.58(m), 3.49(m), 3.40(dd), 3.20(d) |
| 17 | Galactose | 5.27(d), 3.83(m), 4.02(m) |
| 18 | Sucrose | 5.41(d), 4.21(d), 4.05(t), 3.82(m), 3.68(s), 3.56(dd), 3.47(t) |
| 19 | Raffinose | 5.47(d), 4.27(d), 4.08(m), 4.00(t), 3.94(m), 3.88(m), 3.83(m), 3.80(d), 3.74(d), 3.72(s), 3.61(m) |
| 20 | Melibiose | 5.30(d), 4.06(m), 4.03(m), 3.88(m), 3.84(m), 3.78(m), 3.71(dd), 3.66(m), 3.57(m), 3.32(m) |
| 21 | Stachyose | 5.44(d), 5.01(dd), 4.79(m), 4.24(d), 4.16(dd), 4.07(m), 4.00(d), 3.82(m), 3.57(m), 1.19(t) |
| 22 | Fumarate | 6.56(s) |
| 23 | Danshensu (DSS) | 6.86(d), 6.81(d), 6.74(dd), 5.42(m), 2.85(m), 3.04(m) |
| 24 | Salvianolic acid B (SaB) | 6.99(m), 6.76(m), 6.42(d), 6.24(d), 6.12(dd), 6.01(d), 5.85(d), 5.00(m), 4.90(m), 4.33(d), 3.10(m), 2.98(m), 2.90(m), 2.56(m) |
| 25 | Rosmarinic acid (RA) | 7.49(d), 6.98(d), 6.89(d), 6.72(d), 6.64(d), 6.55(dd), 6.32(d), 3.13(m), 2.92(m) |
| 26 | Lithospermic acid (LA) | 7.98(d), 6.26(d) |
| 27 | Salvianolic acid A (SaA) | 8.02(d), 6.24(d) |
| 28 | Procatechuic aldehyde (PA) | 9.63(d), 7.08(dd), 6.80(d) |
| 29 | Procatechuic acid | 7.41(d), 7.46(dd) |
| 30 | 5-Hydroxymethyl furfural | 9.45(s), 7.23(d), 6.51(d), 4.56(d), 3.27(t) |
Fig. 2Multivariate analysis results based on the 1H NMR data of intermediates: (A) PLS-DA score plot, (B) scores scatter plot t1 vs. u1, (C) permutation test model validation plot, (D) dendrogram of the hierarchical clustering (sample names are identified by the intermediate name accompanying the batch number, such as A-1, which represents the intermediate A collected from the production batch 1.).
Fig. 3(A) PCA results based on 1H NMR data (0.6–9.9 ppm) of intermediates A and B, (B) OPLS-DA score plot, (C) permutation test model validation plot of OPLS-DA model, (D) S-plot of the OPLS-DA model.
Fig. 4(A) PCA results based on 1H NMR data (5.60–9.90 ppm) of intermediates A and B, (B) OPLS-DA score plot, (C) permutation test model validation plot of OPLS-DA model, (D) S-plot of OPLS-DA model.
Fig. 5(A) PCA results based on 1H NMR data (0.60–3.30 ppm) of intermediates A and B, (B) OPLS-DA score plot, (C) validation of the corresponding partial least squares discriminant analysis model via a permutation test, (D) S-plot of OPLS-DA model.